SCHEMBL23047422

SCHEMBL23047422

CCOC(=O)c1cc(OC)c(OCc2ccc(F)cc2)cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPC6 Q9Y210 2/20 0.52
POLB P06746 2/20 0.47
CSF1R P07333 1/20 0.46
FFAR1 O14842 1/20 0.46
FFAR4 Q5NUL3 1/20 0.46
MAOB P27338 2/20 0.44
GABRA1 P14867 3/20 0.43
GABRG2 P18507 3/20 0.43
GABRB3 P28472 3/20 0.43
GABRA5 P31644 3/20 0.43
GABRA3 P34903 3/20 0.43
GABRA2 P47869 3/20 0.43
MMP13 P45452 2/20 0.43
GABRP O00591 2/20 0.43
GABRD O14764 2/20 0.43
GABRB1 P18505 2/20 0.43
GABRB2 P47870 2/20 0.43
GABRA4 P48169 2/20 0.43
GABRE P78334 2/20 0.43
GABRA6 Q16445 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045835 0.89 TRPC6 (0.55) TRPC6CSF1RFFAR1FFAR4MAPT
SCHEMBL30439720 0.89 TRPC6 (0.55) TRPC6CSF1RFFAR1FFAR4MAPT
SCHEMBL15351024 0.88 MAOB (0.46) POLBFFAR1FFAR4MAOBGABRA1
SCHEMBL21045916 0.85 TRPC6 (0.56) TRPC6FFAR1FFAR4PLA2G1BATG4B
SCHEMBL23047421 0.81 TRPC6 (0.54) TRPC6GABRA1GABRG2GABRB3GABRA5
SCHEMBL22978588 0.78 GABRA1 (0.48) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL10530987 0.78 POLB (0.55) POLBFFAR1MAOBMAPTSMN1; SMN2
SCHEMBL5806655 0.76 TRPC6 (0.53) TRPC6MAPTSMN1; SMN2CYP1A2CYP3A4
SCHEMBL15776567 0.76 CNR2 (0.55) TRPC6FFAR4MAPTALDH1A1HTT
SCHEMBL1424950 0.75 GABRA1 (0.50) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3786160-B1 PYRIDINE DERIVATIVES AND THERAPEUTIC USES THEREOF AS TRPC6 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2022-07-13 EP disclosed
EP-3786160-A1 PYRIDINE DERIVATIVES AND THERAPEUTIC USES THEREOF AS TRPC6 INHIBITORS Boehringer Ingelheim International GmbH (DE) 2021-03-03 EP disclosed